Capecitabine in the treatment of patiens with colorectal carcinoma

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F04%3A00000317" target="_blank" >RIV/62157124:16370/04:00000317 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

čeština

Original language name

Capecitabine v terapii nemocných s kolorektálním karcinomem.

Original language description

The aim of the study was to evaluate the toxicity of the medicinal product Xeloda (capecitabine). The toxicity was monitored in total of seven biochemical parameters. The produkt seams to be relatively safe. Its large advantage is in the posibility of per oral application.

Czech name

Capecitabine v terapii nemocných s kolorektálním karcinomem.

Czech description

The aim of the study was to evaluate the toxicity of the medicinal product Xeloda (capecitabine). The toxicity was monitored in total of seven biochemical parameters. The produkt seams to be relatively safe. Its large advantage is in the posibility of per oral application.

Type

D - Article in proceedings

CEP classification

FR - Pharmacology and apothecary chemistry

OECD FORD branch

—

Project

<a href="/en/project/NL7455" target="_blank" >NL7455: Monitoring of the Dependence of Effect on Dose and of Basic Pharmacokinetic Parameters in Original Substances with Antioxidative Effect</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2004

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Article name in the collection

Farmaceutický obzor

ISBN

0014-8172

ISSN

—

e-ISSN

—

Number of pages

1

Pages from-to

289

Publisher name

Herba spol. s.r.o.

Place of publication

Bratislava

Event location

Nitra

Event date

Sep 9, 2004

Type of event by nationality

EUR - Evropská akce

UT code for WoS article

—